Peptide library › Digestive health
Larazotide acetate
Also known as Larazotide, AT-1001
Experimental gut peptide studied for coeliac disease, aiming to tighten a 'leaky' gut lining.
What people use it for
- Coeliac disease symptoms despite a gluten-free diet (in trials)
What Larazotide acetate does in the body
Designed to block zonulin signalling and help keep the tight junctions between gut-lining cells closed, so less gluten passes through.
Strength of evidence
Limited: early trials suggested symptom benefit, but a Phase 3 trial was stopped in 2022 after an interim analysis.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Generally well tolerated in trials
- Headache and stomach upset
Who should avoid it or take extra care
- Anyone outside a clinical trial
- It does not replace a gluten-free diet
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
Investigational. Not approved by the FDA.
How it's taken
Route: Capsule by mouth, before meals (in trials)
How long it lasts (half-life): Not relevant: designed to work inside the gut
Latest research & news
- Clinical Trial to Evaluate the Protective Effect of Larazotide Acetate in Individuals With Well-Controlled Celiac Disease
Clinical trial · Not yet recruiting · Phase 3 · Updated · ClinicalTrials.gov · 20 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Larazotide acetate privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Larazotide acetate in Fiala How to installMore in Digestive health
- TeduglutideDaily injection that helps the remaining gut absorb more in short bowel syndrome, reducing the need for IV nutrition.
- ApraglutideExperimental once-weekly GLP-2 medicine for short bowel syndrome.
- GlepaglutideExperimental long-acting GLP-2 medicine for short bowel syndrome, given once or twice a week.
- LinaclotideDaily capsule for constipation and IBS with constipation; works inside the gut and is barely absorbed.
- PlecanatideDaily tablet for chronic constipation and IBS with constipation, similar to linaclotide.
- PN-943Experimental gut-targeted tablet for ulcerative colitis that blocks immune cells from entering the bowel.
- SecretinGut hormone given during tests to check how well the pancreas works and to find certain tumours.
- SincalideShort form of the gut hormone CCK, used during scans to make the gallbladder squeeze.